维普期刊资源整合服务平台（V6.5）

244篇 您的检索式：作者名="DEHDASHTI F"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	MRI,^18F—FDG PET/CT及PET/MR成像评估妇科肿瘤显示文摘MRI和^18F-脱氧葡萄糖(FDG)PET/CT在妇科癌症患者的诊疗中扮演着核心和互补角色。由于治疗通常需要联合手术、放疗以及化疗,因此成像对病情分期和评估预后非常重要。该文综述了运用上述2种成像模式在早期评估3种常见妇科肿瘤(宫颈癌、子宫内膜癌和卵巢上皮肿瘤)中的应用。重点提出了影响治疗的影像特征,以及2种成像方式的相对优势和不足。影像评估先期治疗后肿瘤复发以及后续姑息治疗方法的选择。并对MRI和PET中较新的功能和分子技术进行效果评估。最后,该文还介绍PET/MR成像的初期经验,PET/MR是一种新型技术,很有潜力成为个体化妇科肿瘤治疗方案制订的重要方法。	王玉彭新桂滕皋军 Susanna I. Lee Catalano OA Dehdashti F	2018	中华核医学与分子影像杂志2018，38，4：	4
2	Utility of FDG- PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer 显示文摘	Flanagan FL Dehdashti F Ogunbiyi OA	1998	Ann Surg1998，227，3：	1
3	Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography显示文摘	Flanagan FL Dehdashti F Siegel BA	1997	Am J Roentgenol1997，168，：	1
4	Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM:relationship to therapeutic response-a preliminary report显示文摘	Dehdashti F Grigsby P W Mintun MA	2003	Int J Radiat Oncol Biol Phys2003，55，5：	1
5	Benign versus malignant introsseous lesions: discrimination by means of PET with 2-(F-18) fluro-2-deoxy-d-glucose 显示文摘	Dehdashti F Siegel BA Griffeth LK	1996	Radiology1996，200，：	1
6	Evaluation of ^111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer:initial clinical results显示文摘	Siegel BA Dehdashti F Mutch DG	2003	J Nucl Med2003，44，5：	1
7	Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer显示文摘	Bradley J D Perez C A Dehdashti F	2004	J Nucl M ed2004，45，1：	1
8	PET-based estradiol challenge as a predictive biomarker of response to endocrine thera- py in women with estrogen-receptor-positive breast cancer 显示文摘	Dehdashti F Mortimer JE Trinkaus K	2009	Breast Cancer Res Treat2009，113，3：	1
9	In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM显示文摘	Dehdashti F Mintun MA Lewis JS	2003	Eur J Nucl Med Mol Imaging2003，30，6：	1
10	Improved prognostic value of 18 F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer显示文摘	Miller TR Pinkus E Dehdashti F	2003	J Nucl Med2003，44，2：	1
11	Evaluation of ^111In-DTPA-Folate as a Receptor-Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results显示文摘	Siegel BA Dehdashti F Mutch DG	2003	J Nucl Med2003，44，5：	1
12	Positron tomographic assessment of 16-alpha-fluoro-17-beta-estradiol uptake in metastatic breast carcinoma显示文摘	McGuire AH Dehdashti F Siegel BA	1991	J Nucl Med1991，32，8：	1
13	FDG-PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features 显示文摘	Berger KL Nicholson SA Dehdashti F	2000	Am J Roentgenol2000，174，4：	1
14	Whole-body positron emission tomography nomal variations pitfalls and technical considerations显示文摘	Gordon BA Flanagan FL Dehdashti F	1997	AJR1997，169，：	1
15	Positron emission tomographic assessment of 'metabolic flare' to predict response of metastatic breast cancer to antiestrogen therapy显示文摘	Dehdashti F Flanagan FL Mortimer JE	1999	Eur J Nucl Med1999，26，1：	1
16	Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer显示文摘	Kidd EA Siegel BA Dehdashti F	2010	Int J Radiat Oncol Biol Phys2010，77，4：	1
17	Metabolic flare:indicator of hormone responsiveness in advanced breast cancer显示文摘	Mortimer JE Dehdashti F Siegel BA	2001	J Clin Oncol2001，19，：	1
18	Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography显示文摘	Flanagan FL Dehdashti F Siegel BA	1997	AJR1997，168，：	1
19	Lymph node staging by position emission tomography in patients with carci nomaof the cervix显示文摘	GRIGSBY F W SIEGOL B A DEHDASHTI F	2001	J Clin Oncol2001，19，17：	1
20	In vivo assessment of tumor hypoxia in lung cancer with ^60Cu-ATSM 显示文摘	Dehdashti F Mintun MA Lewis JS	2003	Eur J Nucl Med Mol Imaging2003，30，：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示